Publications

Search our bibliography using the filters on the right-hand side.

Displaying 1 through 50 of 89 publications.

Rothman KJ, Arellano FM, Young-Xu Y, Simonsen L. Reply to gargiullo et Al. J Infect Dis. 2006 Dec 15;194(12):1794-5.

Rothman KJ, Arellano FM, Young-Xu Y, Simonsen L. Reply to "is there a safe age for vaccinating infants with tetravalent rhesus-human reassortant rotavirus vaccine?". J Infect Dis. 2006 Dec;194(12):1793-4.

Seeger JD, West WA, Fernandez C, Rivero E. Pregnancy and pregnancy outcome among women with inflammatory skin diseases. Dermatology. 2006 Dec 1;214(1):32-9.

Perez-Gutthann S, Cook S, Dai W, Hirst C, Andrews E. A call for international harmonization in therapeutic risk management. Pharmacoepidemiol Drug Saf. 2006 Dec 1;15(12):839-49.

Arellano FM, Yood MU, Wentworth CE, Oliveria SA, Rivero E, Verma A, Rothman KJ. Use of Cyclo-Oxygenase 2 Inhibitors (COX-2) and prescription Non-Steroidal Anti-Inflammatory Drugs (NSAIDS) in UK and USA populations. Implications for COX-2 cardiovascular profile. Pharmacoepidemiol Drug Saf. 2006 Dec 1;15(12):861-72.

Sorensen HT, Pedersen L, Norgaard M, Rothman KJ, Lash TL. No excess risk of breast cancer in mothers of boys with hypospadias. Epidemiology. 2006 Nov 30;17(6):706-7.

Gonzalez-Perez A, Fernandez-Vidaurre C, Rueda A, Rivero E, Garcia-Rodriguez LA. Cancer incidence in a general population of asthma patients. Pharmacoepidemiol Drug Saf. 2006 Nov 15;15(2):131-8.

Sorensen HT, Lash T, Rothman KJ. Beyond randomized controlled trials. A critical comparison of trials with non-randomized studies. Hepatology. 2006 Nov;44(5):1075-82. doi: 10.1002/hep.21404

Maxwell GL, Schildkraut JM, Calingaert B, Risinger JI, Dainty L, Marchbanks PA, Berchuck A, Barrett JC, Rodriguez GC. Progestin and estrogen potency of combination oral contraceptives and endometrial cancer risk. Gynecol Oncol. 2006 Nov 1;103(2):535-40.

Mathews R, Leiss J, Vanderpuije A. Completion of high school among teenage mothers in North Carolina: a prospective study using maternally linked birth records. Poster presented at the 134th Annual Meeting of the American Public Health Association; November 2006.

Sexton JB, Makary MA, Tersigni AR, Pryor D, Hendrich A, Thomas EJ, Holzmueller CG, Knight AP, Wu Y, Pronovost PJ. Teamwork in the operating room: frontline perspectives among hospitals and operating room personnel. Anesthesiology. 2006 Nov;105(5):877-84.

Heurta C, Castellsague J, Garcia Rodriquez LA, Varas-Lorenzo C. Nonsteroidal anti-inflammatory drugs and risk of first hospital admission for heart failure in the general population. Heart. 2006 Nov;92(11):1610-5.

Jick H, Kaye JA, Russmann S, Jick SS. Nonsteroidal antiinflammatory drugs and acute myocardial infarction in patients with no major risk factors. Pharmacotherapy. 2006 Oct;10:1379-87.

Cook MN. Estimating national drug consumption using data at different points in the pharmaceutical supply chain. Pharmacoepidemiol Drug Saf. 2006 Oct;15(10):754-7.

Sturmer T, Rothman KJ, Glynn RJ. Insights into different results from different causal contrasts in the presence of effect-measure modification. Pharmacoepidemiol Drug Saf. 2006 Oct 1;15(10):698-709.

Appt SE, Clarkson TB, Lees CJ, Anthony MS. Low dose estrogens inhibit coronary artery atherosclerosis in postmenopausal monkeys. Maturitas. 2006 Sep 20;55(2):187-94.

Rubino A, Davis KL, Wang J, Rousculp MD, Tzivelekis S, Girach A. Prevalence of diagnosed diabetic retinopathy and its severity in four European countries. Poster presented at the 42nd Annual Meeting of the European Association for the Study of Diabetes; September 17, 2006. Previously presented at the 66th Scientific Session of the American Diabetes Association.

Rubino A, Davis KH, Wang J, Rousculp MD, Tzivelekis S, Girach A. Prevalence of diagnosed diabetic retinopathy (DR) and symptoms in four European countries. Poster presented at the 42nd Annual Meeting of the European Association for the Study of Diabetes; September 17, 2006.

West R, Gilsenan A, Coste F, Zhou X, Brouard R, Nonnemaker J, Curry SJ, Sullivan SD. The ATTEMPT cohort: a multi-national longitudinal study of predictors, patterns and consequences of smoking cessation; introduction and evaluation of internet recruitment and data collection methods. Addiction. 2006 Sep 1;101(9):1352-61.

Arana A, Varas C, Gonzalez-Perez A, Gutierrez L, Bjerrum L, Garcia Rodriguez LA. Hormonal therapy and cerebrovascular events: a population-based nested case-control study. Menopause. 2006 Sep 1;13(5):730-6.

Rousculp MD, Rubino A, Davis KH, Wang J, Tzivelekis S, Bastyr EJ, Tesfaye S. Prevalence of diagnosed diabetic peripheral neuropathy (DPN) and its symptoms in four European countries. Poster presented at the 42nd Annual Meeting of the European Association for the Study of Diabetes; September 2006.

Cole JA, Rothman KJ, Cabral HJ, Zhang Y, Farraye FA. Migraine, fibromyalgia, and depression among people with IBS: a prevalence study. BMC Gastroenterol. 2006 Sep 1;6(26).

Fortuny J, Kogevinas M, Garcia-Closas M, Real FX, Tardon A, Garcia-Closas R, Serra C, Carrato A, Lloreta J, Rothman N, Villanueva C, Dosemeci M, Malats N, Silverman D. Use of analgesics and nonsteroidal anti-inflammatory drugs, genetic predisposition, and bladder cancer risk in Spain. Cancer Epidemiol Biomarkers Prev. 2006 Sep;15(9):1696-702. doi: 10.1158/1055-9965.EPI-06-0038

Anthony MS, Stephenson JJ, Long S, Lin SL. Low prevalence of bisphosphonate therapy among long-term glucocorticoid users. Poster presented at the 28th Annual Meeting of the American Society for Bone and Mineral Research; September 2006. Philadelphia, PA. [abstract] J Bone Miner Res. 2006 Sep; 21(Suppl 1):S281.

Fireman B, Mines D, Lee J, Hunkeler EM. The risk of suicide in patients treated with venlafaxine, fluoxetine, citalopram, or paroxetine at Kaiser Permanente in Northern California. Poster presented at the 2006 Summer Meeting of the British Association for Psychopharmacology; July 2006. Oxford, United Kingdom. [abstract] J Psychopharmacol. 2006 Sep; 20(5 Suppl):A58.

Miller DP, Bennett L, Hollis KA, Tennis P, Cook SF, Andrews E. A patient follow-up survey programme for alosetron: assessing compliance to and effectiveness of the risk management programme. Aliment Pharmacol Ther. 2006 Sep 1;24(5):869-78.

Rubino A, McQuay L, Kvasz M, Tennis P. Population-based study of time to insulin after failure of oral antidiabetic therapy in type 2 diabetes in the UK. Poster presented at the 22nd ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 30, 2006. Lisbon, Portugal. Previously presented at the American Diabetes Association's 66th Annual Scientific Sessions.

Rubino A, Evans SJ, Smeeth L. Risk of Stroke During Treatment with Atypical and Conventional Antipsychotics: a Population-Based Study in the United Kingdom. Poster presented at the 22nd ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 30, 2006. Lisbon, Portugal.

Lanza LL, Wang L, Simon T, Irish W. Risk of Selected Outcomes After Solid Organ Transplantation: a Literature Review. Poster presented at the 22nd ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 28, 2006. Lisbon, Portugal.

Nyberg F, Hada S, Rothman KJ. Iressa and interstitial lung disease (ILD) in Japan - Lessons from a large nested case-control study to evaluate a safety issue. Poster presented at the 22nd ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 28, 2006. Lisbon, Portugal.

Gilsenan A, Zhou X, Coste F, Allshouse AA. Comparison of data from a US national survey (NHANES) with data from a cohort recruited from the internet. Poster presented at the 22nd ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 28, 2006. Lisbon, Portugal.

Varas-Lorenzo C, McQuay L, Eaton S, Saez-Lloret I, Melero-Montes M, Miller D, Perez-Gutthann S. Characterization of US adult users of antihypertensive medications. Poster presented at the 22nd ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 28, 2006. Lisbon, Portugal.

Sanchez Matienzo D, Lanza LL, McQuay L, Gutierrez L, Arana Navarro A, Perez-Gutthann S. Descriptive study of users of depo-medroxyprogesterone acetate (DMPA) in the mhra gprd. Presented at the 22nd ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 27, 2006. Lisbon, Portugal.

Cook MN, Nelson RC, Hennessy S, Buring JE. Increased transparency to improve the credibility of pharmacoepidemiologic studies submitted to regulatory agencies and journals? Presented at the 22nd ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 24, 2006. Lisbon, Portugal.

Rothman KJ. Thrombosis after travel. PLoS Med. 2006 Aug 22;3(8):e30.

Mosis G, Stijnen T, Castellsague J, Dieleman JP, Van der Lei J, Stricker BHC, Sturkenboom MCJM. Channeling and prevalence of cardiovascular contraindications in users of cyclooxygenase 2 selective nonsteroidal antiinflammatory drugs. Arthritis Care Res (Hoboken). 2006 Aug 15;55(4):537-42.

Gutierrez LP, Moy E, Eagle C. Use of the registry methodology in a rare disease setting: the Familial Adenomatous Polyposis (FAP) Registry-based study. Poster presented at the 22nd International Conference on Pharmacoepidemiology & Therapeutic Risk Managemen; August 2006. Lisbon, Portugal. [abstract] Pharmacoepidemiol Drug Saf. 2006 Aug; 15(1):S216-464.

Yood MU, Lafata JE, Koro C, Wells KE, Pladevall-Vila M. Time to pharmacotherapy change in response to elevated HbA(1c) test results. Curr Med Res Opin. 2006 Aug;22(8):1567-74.

Hartford CG, Petchel KS, Mickail H, Perez-Gutthann S, McHale M, Grana JM, Marquez P. Pharmacovigilance during the pre-approval phases: an evolving pharmaceutical industry model in response to ICH E2E, CIOMS VI, FDA and EMEA/CHMP risk-management guidelines. Drug Saf. 2006 Aug 1;29(8):657-73. doi: 10.2165/00002018-200629080-00003

Seeger JD, Ziyadeh N, Lievano F, Rivero E, Earnest DL, Shetzline M, Holden W, Walker AM. Nested case-control validation of results of the Zelnorm™ epidemiological study. Presented at the 22nd International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2006. Lisbon, Portugal. [abstract] Pharmacoepidemiol Drug Saf. 2006 Aug; 15(Suppl 1):S32.

Seeger JD, Quinn S, Lievano F, Rivero E, Earnest DL, Shetzline M, Holden W, Walker AM. No increased risk of abdominal or pelvic surgery associated with tegaserod exposure: the zelnormTM epidemiological study. Presented at the 22nd International Conference on Pharmacoepidemiology & Therapeutic Risk Management,; August 2006. Lisbon, Portugal. [abstract] Pharmacoepidemiol Drug Saf. 2006 Aug; 15(Suppl 1):S12-3.

Huerta C, Rivero E, Gil M, Garcia-Rodriguez LA. Incidence and natural history of psoriasis diagnosed in general practice. Poster presented at the 22nd International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2006. Lisbon, Portugal. [abstract] Pharmacoepidemiol Drug Saf. 2006 Aug; 15(Suppl 1):S275-6.

Huerta C, Montoro MA, Sanchez B, Rivero E, Lievano F, Garcia-Rodriguez LA. Incidence and risk factors for intestinal ischemia. Poster presented at the 22nd International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2006. Lisbon, Portugal. [abstract] Pharmacoepidemiol Drug Saf. 2006 Aug; 15(Suppl 1):S268.

Arellano FM, Wentworth CE, Arana A. Risk of lymphoma following exposure to calcineurin inhibitors and topical steroids in patients with atopic dermatitis. Presented at the 22nd International Conference on Pharmacoepidemiology; August 2006. Lisbon, Portugal.

Varas-Lorenzo C, Maguire A, Castellsague J, Perez-Gutthann S. Quantitative assessment of the gastrointestinal and cardiovascular risk-benefit of celecoxib compared to individual NSAIDs at the population level. Poster presented at the 22nd ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2006. Lisbon, Portugal. [abstract] Pharmacoepidemiol Drug Saf. 2006 Aug; 15(S1):S243.

Varas-Lorenzo C, Stang MR, Tomas L, Gimeno V, Castellsague J, Perez-Gutthann S. Positive predictive value of ICD-9 Code 411 in the identification of cases of acute coronary syndrome in the Saskatchewan Hospital Database. Poster presented at the 22nd ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2006. Lisbon, Portugal. [abstract] Pharmacoepidemiol Drug Saf. 2006 Aug; 15(S1):S231.

Sanchez-Matienzo D, Arana A, Castellsague J, Perez-Gutthann S. Hepatic disorders in patients treated with COX-2 selective inhibitors or nonselective NSAIDs: a case/noncase analysis of spontaneous reports. Clin Ther. 2006 Aug 1;28(8):1123-32.

Rubino A, Mines D, Roskell NS, Tennis P, Andrews E, Welch S. Risk of suicide during venlafaxine treatment compared with citalopram, fluoxetine, and dothiepin treatment: a population-based analysis in the United Kingdom. Poster presented at the British Association for Psychopharmacology Summer Meeting; July 24, 2006.

Lutman CV, Havrilesky LJ, Cragun JM, Secord AA, Calingaert B, Berchuck A, Clarke-Pearson DL, Soper JT. Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histology. Gynecol Oncol. 2006 Jul 1;102(1):92-7.

Lancaster JM, Sayer RA, Blanchette C, Calingaert B, Konidari I, Gray J, Schildkraut J, Schomberg DW, Marks JR, Berchuck A. High expression of insulin-like growth factor binding protein–2 messenger RNA in epithelial ovarian cancers produces elevated preoperative serum levels. Int J Gynecol Cancer. 2006 Jul 1;16(4):1529-35.